Gianpietro Dotti

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

98h-index38.3kcitations701works6.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(553), Immune Cell Function and Interaction(187), Virus-based gene therapy research(158), Immunotherapy and Immune Responses(129), Viral Infectious Diseases and Gene Expression in Insects(69)

Publications698 total

B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer
UNC Libraries·2025Open Access
Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma
UNC Libraries·2025Open Access
CTIM-32. SAFETY AND TOLERABILITY OF INTRAVENTRICULAR INFUSION OF B7-H3.CAR-T CELLS IN RECURRENT GLIOBLASTOMA
Neuro-Oncology·2025
225 ALK.CAR-T cells as a new potential treatment for ALK <sup>+</sup> merkel cell carcinoma
Regular and Young Investigator Award Abstracts·2025Open Access
1221 Optimized syngeneic neuroblastoma models to advance cell therapies
Regular and Young Investigator Award Abstracts·2025Open Access
Abstract B071: ALK.CAR-T cells as a new potential treatment for ALK+ Merkel cell carcinoma
Molecular Cancer Therapeutics·2025
Facts and Hopes of Chimeric Antigen Receptor–Redirected NK T Cells
Clinical Cancer Research·2025· 1 cited
Obesity Impairs the Antitumor Activity of CAR-T Cells in Triple-Negative Breast Cancer
2025Open Access
Abstract A075: A Phase I Study of Autologous CAR-T Cells Targeting the B7-H3 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects with Refractory Pancreatic Ductal Adenocarcinoma (PDAC)
Cancer Research·2025· 1 cited
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Cancer Immunology Immunotherapy·2025Open Access
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults
Open Forum Infectious Diseases·2025· 1 citedOpen Access
CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy
UNC Libraries·2025Open Access
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells
UNC Libraries·2025Open Access
CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy
International Journal of Molecular Sciences·2025Open Access
Abstract P1-07-22: Phase I Study of B7-H3 Specific Chimeric Antigen Receptor (CAR) T Cell Therapy in Patients with Triple-Negative Breast Cancer
Clinical Cancer Research·2025· 1 cited
141 | CD30 CAR‐T IN RELAPSED AND REFRACTORY CD30+ LYMPHOMAS: LONG‐TERM FOLLOW‐UP OF A PHASE IB/II CLINICAL TRIAL
Hematological Oncology·2025· 2 citedOpen Access
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer
Journal for ImmunoTherapy of Cancer·2025· 8 citedOpen Access
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity against neuroblastoma
2025Open Access
Abstract 2159: B7-H3 as a strategic target for CAR-CIK immunotherapy to eliminate chemoresistant cancer stem cells across diverse tumor histotypes
Cancer Research·2025· 1 cited
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Oncogene·2025· 13 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Barbara Savoldo(27), Malcolm K. Brenner(26), Helen E. Heslop(24), Cliona M. Rooney(23), Hao Liu(17), Adrian P. Gee(15), Bambi Grilley(11), Zhen Gu(10), Zhuyong Mei(9), Enli Liu(8), Meng-Fen Wu(8), Carlos A. Ramos(8), Chao Wang(8), Quanyin Hu(8), Olga Dakhova(8), Xudong Zhang(6), Stephen Gottschalk(6), Martin Pulé(5), Rammurti T. Kamble(5), Catherine M. Bollard(5)